Aniridia
Symptoms, Doctors, Treatments, Advances & More

Learn About Aniridia

What is the definition of Aniridia?

Aniridia is an eye disorder that is characterized by a complete or partial absence of the colored part of the eye (the iris). Aniridia is typically present from birth (congenital) and affects both eyes. The pupils may also be abnormal or misshapen.

What are the causes of Aniridia?

Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in the PAX6 gene can cause aniridia. The PAX6 gene provides instructions for making a protein that is involved in the early development of the eyes, brain and spinal cord (central nervous system), and the pancreas. The PAX6 protein belongs to a group of proteins called transcription factors. These proteins bind to specific regions of DNA and regulates the activity of other genes. After birth, the PAX6 protein is found in many different eye structures, where it regulates gene activity.

How prevalent is Aniridia?

Aniridia occurs in 1 in 40,000 to 100,000 newborns worldwide.

Is Aniridia an inherited disorder?

Aniridia is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In approximately two-thirds of cases, a person with aniridia inherits the pathogenic variant from one affected parent. The remaining one-third of cases result from a new (de novo) variant in the gene that occurs during the formation of reproductive cells (eggs or sperm) in an affected individual's parent or during early embryonic development. These affected individuals typically have no history of the disorder in their family.

Who are the top Aniridia Local Doctors?
Elite in Aniridia
Elite in Aniridia
Referral may be required
Linkoeping, E, SE 

Neil Lagali practices practicing medicine in Linkoeping, Sweden. Mr. Lagali is rated as an Elite expert by MediFind in the treatment of Aniridia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Aniridia, Interstitial Keratitis, Spinocerebellar Degeneration and Corneal Dystrophy, Corneal Transplant, and Cataract Removal.

Elite in Aniridia
Elite in Aniridia
Referral may be required
Homburg, SL, DE 

Fabian Fries practices practicing medicine in Homburg, Germany. Mr. Fries is rated as an Elite expert by MediFind in the treatment of Aniridia. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Aniridia, Amebiasis, Interstitial Keratitis, Corneal Transplant, and Vitrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Aniridia
Elite in Aniridia
Referral may be required
39 Mária Str, 
Budapest, BU, HU 

Nora Szentmary practices practicing medicine in Budapest, Hungary. Ms. Szentmary is rated as an Elite expert by MediFind in the treatment of Aniridia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Aniridia, Amebiasis, Keratoconus, Corneal Transplant, and Cataract Removal.

What are the latest Aniridia Clinical Trials?
National Ophthalmic Genotyping and Phenotyping Network, Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Background: The eyeGENE (Registered Trademark) program is a research resource for inherited eye conditions which includes genotypic and phenotypic data, imaging, and a corresponding biobank of DNA samples from people with a variety of eye diseases. Since 2007 this registry has been helping researchers learn more about the genetic sources for many inherited eye diseases. These findings helped them create bette...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Congenital Aniridia Patient Questionnaire

Summary: Congenital aniridia is a pan-ocular genetic disease characterized by a partial or complete absence of the iris, hence its name. The prevalence ranges from 1 / 40,000 to 1 / 96,000 births, but it may be underestimated. This condition combines several types of eye damage and could associate systemic manifestations, with a variable phenotype and genotype. This study aims to identify eye and systemic ...

Who are the sources who wrote this article ?

Published Date: April 09, 2026
Published By: National Institutes of Health